Old Web
English
Sign In
Acemap
>
authorDetail
>
Theresa Andreasson
Theresa Andreasson
AstraZeneca
In vivo
Medicine
Peripheral blood mononuclear cell
In vitro
Pharmacology
4
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Supersaturated formulations of poorly soluble weak acid drugs evaluated in rodents; a case study.
2021
International Journal of Pharmaceutics
Kalle Sigfridsson
Theresa Andreasson
Britt-Marie Fihn
Martin Kearns
Sara Lindblom
Show All
Source
Cite
Save
Citations (0)
A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
2020
PLOS ONE
Céline Dumont
Ulf Sivars
Theresa Andreasson
Lina Odqvist
Johan Mattsson
Amy DeMicco
Katerina Pardali
Gustav Johansson
Linda Yrlid
Rhona Jane Cox
Frank Seeliger
Marie Larsson
Ulf Gehrmann
Andrew M. Davis
Outi Vaarala
Show All
Source
Cite
Save
Citations (5)
Pharmacological properties of novel LTC4 synthase inhibitor
2017
European Respiratory Journal
Pernilla Glader
Fanyi Jiang
Ann Aurell Holmberg
Corinne Hamblet
Eva Lamm Bergström
Kristensson Lisbeth
Fredrik Wågberg
Anders Lundqvist
Linda Swedin
Mattias Rohman
Johanna Vinblad
Britt-Marie Wissing
Theresa Andreasson
Louise Hafsten
Henrik Bergquist
Magnus Munck Af Rosenschold
Andrew M. Davis
Show All
Source
Cite
Save
Citations (0)
Direct relationship between inhibition of leukotriene release in lung and free plasma concentration of a LTC4synthase inhibitor in a rat model
2015
European Respiratory Journal
Linda Swedin
Eva Lamm Bergström
Theresa Andreasson
Magnus Munck Af Rosenschold
Britta Bonn
Andrew M. Davis
Show All
Source
Cite
Save
Citations (0)
1